Morepen Laboratories Share Price | Morepen Laboratories Stock Screener
MOREPENLAB
Pharmaceuticals
Share Price NSE
₹53.80
▲
1.35 (2.57%)
Share Price BSE
₹53.79
▲
1.35 (2.57%)
As of July 24, 2026, the Morepen Laboratories share price (NSE: MOREPENLAB) is ₹53.80 on NSE and ₹53.79 on BSE, up 2.57% from the previous close, with shares trading between ₹51.38 and ₹54.19, and a 52-week range of ₹33.68–₹62.68.
Analyse MOREPENLAB share price data and track historical price performance.
Use the Morepen Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Morepen Laboratories Market Cap
₹2,915.11 Cr.
MOREPENLAB P/E Ratio (TTM)
32.48
Morepen Laboratories P/B Ratio
2.50
EPS (TTM)
₹1.73
Dividend Yield
0.35%
Debt to Equity
0.07
MOREPENLAB 52 Week High
₹62.68
Morepen Laboratories 52 Week Low
₹33.68
Operating Margin
5.00%
Profit Margin
3.25%
MOREPENLAB Revenue (TTM)
₹493.00
EBITDA
₹33.00
Net Income
₹16.00
Total Assets
₹1,936.00
Total Equity
₹1,246.00
Morepen Laboratories Share Price Chart
Screen Morepen Laboratories share price with an interactive chart. Analyse MOREPENLAB price trends and volatility across different timeframes.
Morepen Laboratories Company Profile - Fundamental Screener
Screen Morepen Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MOREPENLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE083A01026
Morepen Laboratories Balance Sheet Screener
Screen MOREPENLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,936 | 1,778 | 1,293 | 1,111 | 1,070 | 858 | 664 | 615 | 586 | 538 |
| Current Assets | 1,164 | 1,159 | 889 | 756 | 734 | 527 | 372 | 300 | 243 | 192 |
| Fixed Assets | 535 | 489 | 307 | 267 | 252 | 225 | 216 | 236 | 264 | 272 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 199 | 91 | 44 | 37 | 36 | 30 | 28 | 23 | 20 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,246 | 1,187 | 847 | 752 | 578 | 424 | 284 | 253 | 226 | 196 |
| Share Capital | 110 | 110 | 102 | 102 | 96 | 90 | 90 | 90 | 90 | 90 |
| Reserves & Surplus | 1,137 | 1,047 | 745 | 651 | 457 | 291 | 194 | 163 | 136 | 106 |
Morepen Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Morepen Laboratories income statement and profit fundamentals.
Analyze MOREPENLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Morepen Laboratories share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 493 | 488 | 442 | 430 | 471 | 458 | 443 | 459 | 427 | 449 | 425 | 404 | 367 | 350 | 404 |
| Expenses | 460 | 438 | 381 | 401 | 424 | 417 | 394 | 404 | 375 | 394 | 388 | 375 | 348 | 328 | 374 |
| EBITDA | 33 | 50 | 61 | 29 | 47 | 42 | 49 | 55 | 53 | 55 | 37 | 29 | 19 | 22 | 30 |
| Operating Profit % | 5.00% | 10.00% | 7.00% | 6.00% | 9.00% | 8.00% | 10.00% | 11.00% | 11.00% | 11.00% | 8.00% | 7.00% | 4.00% | 6.00% | 7.00% |
| Depreciation | 6 | 10 | 11 | 9 | 17 | 5 | 2 | 6 | 10 | 8 | 8 | 8 | 7 | 7 | 7 |
| Interest | 4 | 4 | 4 | 4 | 5 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 23 | 35 | 46 | 16 | 26 | 35 | 46 | 48 | 42 | 44 | 29 | 21 | 11 | 14 | 22 |
| Tax | 8 | 8 | 5 | 4 | 5 | 9 | 11 | 12 | 14 | 12 | 7 | 6 | 3 | 5 | 7 |
| Net Profit | 16 | 28 | 41 | 11 | 20 | 27 | 35 | 36 | 29 | 32 | 21 | 15 | 8 | 9 | 16 |
| EPS | 0.28 | 0.50 | 0.75 | 0.20 | 0.35 | 0.49 | 0.65 | 0.71 | 0.54 | 0.63 | 0.42 | 0.29 | 0.16 | 0.15 | 0.33 |
Morepen Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen MOREPENLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 32 | 73 | -91 | -60 | 51 | 11 | 17 | 63 | 41 | 50 |
| Investing Activities | -322 | -83 | -47 | -32 | -70 | -13 | -13 | -27 | -14 | -27 |
| Financing Activities | 300 | 5 | 144 | 66 | 47 | 6 | 0 | -38 | -24 | -27 |
| Net Cash Flow | 10 | -5 | 6 | -26 | 28 | 4 | 4 | -1 | 3 | -5 |
Morepen Laboratories Shareholding Pattern Screener
See Morepen Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Morepen Laboratories promoter holding and ownership changes for MOREPENLAB on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% | 38.22% | 38.22% |
| FII Holding | 1.59% | 1.46% | 1.94% | 1.72% | 1.62% | 1.62% | 1.85% | 1.67% |
| DII Holding | 1.25% | 1.28% | 1.67% | 1.51% | 1.50% | 1.25% | 2.15% | 2.15% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 50.03% | 49.75% | 48.76% | 49.35% | 49.96% | 50.28% | 45.03% | 45.22% |
| Other Holding | 11.47% | 11.84% | 11.96% | 11.76% | 11.26% | 11.18% | 12.74% | 12.74% |
| Shareholder Count | 447,286 | 434,912 | 468,860 | 461,180 | 461,853 | 453,137 | 336,019 | 348,766 |
Morepen Laboratories Share Dividend Screener - Share Yield Analysis
Check Morepen Laboratories dividend history with payout and yield data.
View Morepen Laboratories dividend details including ex-dates and amounts for MOREPENLAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.20 | 0.59% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Morepen Laboratories Stock Index Membership
See which indices include Morepen Laboratories stock.
Check MOREPENLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Morepen Laboratories Market Events Screener - Corporate Actions
Get Morepen Laboratories corporate actions including splits, bonuses, and buybacks.
Check Morepen Laboratories stock events that may affect MOREPENLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | 1.70% |
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 10.03% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -1.79% |
| 2025-09-06 | 2025-09-06 | Annual General Meeting | NA | -12.82% |
| 2025-08-29 | 2025-08-30 | Dividend | ₹ 0.20 /share | -17.00% |
| 2025-08-06 | 2025-08-06 | Quarterly Result Announcement | NA | -3.23% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -5.11% |
| 2025-02-10 | 2025-02-10 | Extraordinary General Meeting | NA | -10.10% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 3.02% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 1.20% |
| 2024-09-28 | 2024-09-28 | Annual General Meeting | NA | -9.94% |
| 2024-03-18 | 2024-03-18 | Extraordinary General Meeting | NA | -21.28% |
| 2023-02-02 | 2023-02-02 | Change Of Name | NA | 0.00% |
Morepen Laboratories Competitors Screener - Peer Comparison
Screen MOREPENLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 466,191 | 40.90 | 61,674 | 12.69% | 11,565 | 61.52 |
| Divis Laboratories | 196,088 | 75.78 | 11,067 | 13.95% | 2,568 | 73.60 |
| Torrent Pharmaceuticals | 191,454 | 79.75 | 13,886 | 20.34% | 2,138 | 66.10 |
| Cipla | 114,318 | 29.97 | 29,045 | 2.24% | 3,870 | 47.02 |
| Zydus Life Science | 113,332 | 22.27 | 27,658 | 17.64% | 5,026 | 51.92 |
| Lupin | 110,051 | 21.47 | 29,039 | 26.75% | 5,356 | 47.81 |
| Mankind Pharma | 105,095 | 54.93 | 14,636 | 14.85% | 1,938 | 55.85 |
| Dr Reddys Laboratories | 98,725 | 24.22 | 35,059 | 3.90% | 4,158 | 29.50 |
| Aurobindo Pharma | 88,240 | 26.21 | 33,385 | 3.21% | 3,376 | 49.50 |
| Laurus Labs | 85,179 | 96.66 | 6,868 | 22.01% | 890 | 64.23 |
Morepen Laboratories Company Announcements - News Screener
Screen MOREPENLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-06 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-07-01 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-06-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-10 | Reply To Clarification On Price Movement | - |
| 2026-06-10 | Clarification sought from Morepen Laboratories Ltd | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | - |
| 2026-05-26 | Corporate Action-Board approves Dividend | - |
| 2026-05-26 | Please Find Attached Quarter And Financial Year Ended March 31 2026 Financial Results | - |
| 2026-05-26 | Board Meeting Outcome for Board Meeting Outcome For Q4 And FY26 Results | - |
| 2026-05-21 | Update on board meeting | - |
| 2026-05-20 | Announcement under Regulation 30 (LODR)-Restructuring | - |
| 2026-05-15 | Board Meeting Intimation for Q-4 And FY 2026 Results. | - |
| 2026-05-11 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-06 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-04-23 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | - |